ADT Inc ( ADT ) Monday announced a proposed secondary public offering of 102,000,366 shares of the company’s common stock held by certain entities managed by affiliates of Apollo Global Management ( APO ). The company is not selling any shares and will not receive any proceeds from the proposed offering. In addition, ADT ( ADT ) intends to purchase from the underwriters up to 29,142,961 shares of ...
ADT Inc ( ADT ) Monday announced a proposed secondary public offering of 102,000,366 shares of the company’s common stock held by certain entities managed by affiliates of Apollo Global Management ( APO ). The company is not selling any shares and will not receive any proceeds from the proposed offering. In addition, ADT ( ADT ) intends to purchase from the underwriters up to 29,142,961 shares of common stock as part of the secondary public offering, subject to the completion of the offering. The share repurchase will be made pursuant to the company’s existing $1.5B share repurchase plan. More on ADT ADT Inc. (ADT) Q1 2026 Earnings Call Transcript ADT Inc. 2026 Q1 - Results - Earnings Call Presentation ADT: Business Needs To Show Earnings Growth ADT Non-GAAP EPS of $0.23, revenue of $1.28B ADT Q1 2026 Earnings Preview
巴克莱的经济学家将其美联储政策预测调整为到明年年底前仅降息一次，即在2027年3月份降息，依据是他们预计能源价格将保持高位。此前，他们预测美联储将在2026年9月份和2027年3月份各降息25个基点。 Marc Giannoni和Jonathan Millar在一份报告中称：“由于伊朗冲突，能源价格预计将在整个2027年保持高位，我们上调了核心通胀的轨迹，并小幅下调了增长预测，”并且“不再认为联邦...
巴克莱的经济学家将其美联储政策预测调整为到明年年底前仅降息一次，即在2027年3月份降息，依据是他们预计能源价格将保持高位。此前，他们预测美联储将在2026年9月份和2027年3月份各降息25个基点。 Marc Giannoni和Jonathan Millar在一份报告中称：“由于伊朗冲突，能源价格预计将在整个2027年保持高位，我们上调了核心通胀的轨迹，并小幅下调了增长预测，”并且“不再认为联邦公开市场委员会今年将能够降息”。 他们维持这样的观点，即美联储将在“看到通胀正朝着其2%目标回落的明确证据时”降息。 “在2027年3月份降息后，我们预计联邦公开市场委员会将在较长一段时间内按兵不动，直到新的冲击迫使其改变政策利率。” 责任编辑：陈钰嘉
ADC Therapeutics press release ( ADCT ): Q1 Non-GAAP EPS of -$0.13. Revenue of $20.85M (-9.5% Y/Y) beats by $0.86M . Net product revenues were $20.0 million for the first quarter of 2026, as compared to $17.4 million for the first quarter of 2025. The increase in revenue versus the prior year was primarily driven by volume increase, which reflects the normal variability in customer ordering patter...
ADC Therapeutics press release ( ADCT ): Q1 Non-GAAP EPS of -$0.13. Revenue of $20.85M (-9.5% Y/Y) beats by $0.86M . Net product revenues were $20.0 million for the first quarter of 2026, as compared to $17.4 million for the first quarter of 2025. The increase in revenue versus the prior year was primarily driven by volume increase, which reflects the normal variability in customer ordering patterns as well as higher price. License Revenues and Royalties: License revenue and royalties were $0.8 million for the first quarter of 2026, as compared to $5.6 million for the first quarter of 2025. The decrease was primarily driven by a prior year milestone received from our partner. Cash and cash equivalents of $231.0 million as of March 31, 2026, with an expected cash runway at least into 2028 More on ADC Therapeutics ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Strategy, Clinical Progress, and Sales Growth Outlook Transcript ADC Therapeutics SA 2025 Q4 - Results - Earnings Call Presentation ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript ADC Therapeutics outlines $600M–$1B peak revenue target for ZYNLONTA as LOTIS-5 and LOTIS-7 advance Seeking Alpha’s Quant Rating on ADC Therapeutics
AMD Ryzen AI Max+ PRO 495 APU could arrive with 192GB of unified memory — leaked PassMark benchmarks suggest modest update over Strix Halo Tom's Hardware
AMD Ryzen AI Max+ PRO 495 APU could arrive with 192GB of unified memory — leaked PassMark benchmarks suggest modest update over Strix Halo Tom's Hardware
A federal appeals court ruling restricts telemedicine access to the abortion drug mifepristone for the whole country, at least temporarily. But another drug that remains available is safe and effective at ending early pregnancy. (Image credit: Robyn Beck)
A federal appeals court ruling restricts telemedicine access to the abortion drug mifepristone for the whole country, at least temporarily. But another drug that remains available is safe and effective at ending early pregnancy. (Image credit: Robyn Beck)
In the last week, the United States market has stayed flat, yet it has experienced a significant rise of 28% over the past 12 months, with earnings expected to grow by 16% per annum in the coming years. In this context of robust growth potential and market stability, identifying high growth tech stocks involves looking for companies with strong innovation capabilities and scalable business models ...
In the last week, the United States market has stayed flat, yet it has experienced a significant rise of 28% over the past 12 months, with earnings expected to grow by 16% per annum in the coming years. In this context of robust growth potential and market stability, identifying high growth tech stocks involves looking for companies with strong innovation capabilities and scalable business models that align well with these positive trends.
Lancaster Colony press release ( MZTI ): Q3 Non-GAAP EPS of $1.45 misses by $0.12 . Revenue of $453.4M (-1.0% Y/Y) misses by $10.63M . Consolidated net sales declined 1.0% to $453.4 million versus $457.8 million last year. Excluding non-core net sales attributed to a temporary supply agreement (“TSA”) with Winland Foods, Inc. that totaled $1.5 million in the current-year quarter and $2.1 million l...
Lancaster Colony press release ( MZTI ): Q3 Non-GAAP EPS of $1.45 misses by $0.12 . Revenue of $453.4M (-1.0% Y/Y) misses by $10.63M . Consolidated net sales declined 1.0% to $453.4 million versus $457.8 million last year. Excluding non-core net sales attributed to a temporary supply agreement (“TSA”) with Winland Foods, Inc. that totaled $1.5 million in the current-year quarter and $2.1 million last year, Adjusted Consolidated Net Sales declined 0.9% to $451.8 million. Retail net sales declined 3.2% to $233.8 million while Foodservice net sales advanced 1.5% to $219.6 million on a reported basis. Excluding the non-core TSA sales, Adjusted Foodservice Net Sales increased 1.8% to $218.1 million. More on Lancaster Colony Marzetti: Volume Growth Nascent, Clear Underweight The Marzetti Company Is Now A Buy After Its Bachan's Purchase (Rating Upgrade) The Marzetti Company: Spicing Things Up With Bachan's Lancaster Colony Q3 2026 Earnings Preview Quant snapshot of best and worst consumer staple stocks ahead of Q1 earnings
Tellus Power has unveiled the Nexus Megawatt Charging System (MCS), a central feature of its innovative Nexus platform aimed at enhancing high-power distributed charging for fleet and commercial applications. The modular system delivers power outputs ranging from 600kW to 1.2MW and supports various charging standards to facilitate deployment across diverse site configurations. Designed to improve ...
Tellus Power has unveiled the Nexus Megawatt Charging System (MCS), a central feature of its innovative Nexus platform aimed at enhancing high-power distributed charging for fleet and commercial applications. The modular system delivers power outputs ranging from 600kW to 1.2MW and supports various charging standards to facilitate deployment across diverse site configurations. Designed to improve energy utilization and power management, the Nexus MCS centralizes power distribution to...
(RTTNews) - Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.
(RTTNews) - Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.
RLJ Lodging Trust press release ( RLJ ): Q1 FFO of $0.33 beats by $0.06 . Revenue of $339.97M (+3.6% Y/Y) beats by $15.73M . Comparable RevPAR of $148.55, an increase of 4.8% over the prior year Comparable Hotel Revenue of $340.0 million, an increase of 5.4% over the prior year FY26 FFO consensus of $1.33 Click to enlarge FY 2026 Comparable RevPAR Growth +1.5% to +3.5% Comparable Hotel EBITDA $356...
RLJ Lodging Trust press release ( RLJ ): Q1 FFO of $0.33 beats by $0.06 . Revenue of $339.97M (+3.6% Y/Y) beats by $15.73M . Comparable RevPAR of $148.55, an increase of 4.8% over the prior year Comparable Hotel Revenue of $340.0 million, an increase of 5.4% over the prior year FY26 FFO consensus of $1.33 Click to enlarge FY 2026 Comparable RevPAR Growth +1.5% to +3.5% Comparable Hotel EBITDA $356M to $380M Adjusted EBITDA $324M to $348M Adjusted FFO per diluted share $1.29 to $1.45 Click to enlarge More on RLJ Lodging Trust RLJ Lodging Trust 2025 Q4 - Results - Earnings Call Presentation RLJ Lodging Trust: One Of The Best High-Yield Opportunities In Today's Market RLJ Lodging Remains A High-Yield REIT That Is Betting On Hotel Upgrades RLJ Lodging Trust Q1 2026 Earnings Preview RLJ Lodging Trust declares $0.15 dividend
MattGush/iStock via Getty Images Rating: Buy (aggressive growth investors) / Hold (everyone else) Current Price: ~$145 12-Month Price Target: $266 (base case) | Bull: $386 | Bear: $125 The Thesis I rate Nebius Group ( NASDAQ: NBIS ) a Buy for aggressive growth investors and a Hold for most others. I had first stumbled across Nebius as I was researching for "AI bottlenecks" back in Jan 2026 where i...
MattGush/iStock via Getty Images Rating: Buy (aggressive growth investors) / Hold (everyone else) Current Price: ~$145 12-Month Price Target: $266 (base case) | Bull: $386 | Bear: $125 The Thesis I rate Nebius Group ( NASDAQ: NBIS ) a Buy for aggressive growth investors and a Hold for most others. I had first stumbled across Nebius as I was researching for "AI bottlenecks" back in Jan 2026 where it was sitting around $60-70 a share. Nebius fits the criteria because it is essentially the AI landlord renting out critical resources such as power, chips and space to major AI consumers/investors such as the Mag7 ( which Nebius has already received investments from! ). There is a years-long queue for companies to connect to the electricity grid. Nebius is skipping the line by building its own data centres at a rapid pace, and still can't keep up with demand. Nebius owns the "bottleneck," giving them massive pricing power over giants like Meta and Microsoft who simply can't find this capacity anywhere else. The disconnect here is straightforward. The market is still partially pricing NBIS like an unproven cloud startup, underestimating the physical moats it is building. In Q4 2025 , Nebius reported $227.7 million (M) in total revenue, up 547% year-over-year. Its core AI-cloud segment grew by 802%, exiting the year with an Annual Recurring Revenue of $1.25 billion (B)— beating management's own guidance range of $900 million to $1.1 billion by 14% at the high end. The company is sold out of capacity. With approximately $46 billion in contracted backlog from Meta Platforms (NASDAQ: META) and Microsoft (NASDAQ: MSFT), the demand is now massively built in. The question that remains is if management can build the data centers fast enough to collect it. What Nebius Actually Is Nebius Group was formed in Europe following the divestment of Yandex's international assets. Arkady Volozh (CEO) had previously built Yandex into a $30 billion tech company and initiated a clean separation ...
In the last week, the United States market has stayed flat, but it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests.
In the last week, the United States market has stayed flat, but it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests.
Many older Americans look at Medicare as a safety net, like Social Security. But while both programs can change from year to year, Social Security benefits usually change for the better. With Social Security, your monthly checks are eligible for an annual cost-of-living adjustment . There are actually provisions to prevent those benefits from decreasing from one year to the next. Image source: Get...
Many older Americans look at Medicare as a safety net, like Social Security. But while both programs can change from year to year, Social Security benefits usually change for the better. With Social Security, your monthly checks are eligible for an annual cost-of-living adjustment . There are actually provisions to prevent those benefits from decreasing from one year to the next. Image source: Getty Images. Continue reading
(RTTNews) - Asian equity markets rallied on Monday tracking Wall Street's strong performance on Friday attributed mainly to strong corporate earnings. The geopolitical stress from the Middle East conflict however capped gains. Markets in China and Japan are closed for a holiday.
(RTTNews) - Asian equity markets rallied on Monday tracking Wall Street's strong performance on Friday attributed mainly to strong corporate earnings. The geopolitical stress from the Middle East conflict however capped gains. Markets in China and Japan are closed for a holiday.